Cutaneous leishmaniasis.
D000666:Amphotericin B / Q000627:therapeutic use; D000965:Antimony / Q000627:therapeutic use; D006801:Humans; D007891:Leishmania / Q000302:isolation & purification; D007896:Leishmaniasis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D010419:Pentamidine / Q000627:therapeutic use; D012867:Skin / Q000469:parasitology
D010419:Pentamidine; D000666:Amphotericin B; D000965:Antimony